Proactiveinvestors USA & Canada Motif Bio PLC https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Motif Bio PLC RSS feed en Mon, 19 Aug 2019 09:21:10 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - NIH to Evaluate Iclaprim Activity against Listeria ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190819070006_14193076/ Mon, 19 Aug 2019 02:00:06 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190819070006_14193076/ <![CDATA[RNS press release - Amended Loan and Security Agreement ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190801070024_14171592/ Thu, 01 Aug 2019 02:00:24 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190801070024_14171592/ <![CDATA[RNS press release - Receipt of Deficiency Notice from Nasdaq ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190726070002_14163989/ Fri, 26 Jul 2019 02:00:02 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190726070002_14163989/ <![CDATA[RNS press release - Motif Bio-Receipt of Deficiency Notice from Nasdaq ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190719070002_14155466/ Fri, 19 Jul 2019 02:00:02 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190719070002_14155466/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190718163046_14155201/ Thu, 18 Jul 2019 11:30:46 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190718163046_14155201/ <![CDATA[RNS press release - US FDA meeting request and package submitted ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190715070004_14148474/ Mon, 15 Jul 2019 02:00:04 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190715070004_14148474/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190628171306_14129964/ Fri, 28 Jun 2019 12:13:06 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190628171306_14129964/ <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190628164058_14129907/ Fri, 28 Jun 2019 11:40:58 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190628164058_14129907/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190628163604_14129893/ Fri, 28 Jun 2019 11:36:04 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190628163604_14129893/ <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190626120748_14125562/ Wed, 26 Jun 2019 07:07:48 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190626120748_14125562/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190626120232_14125546/ Wed, 26 Jun 2019 07:02:32 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190626120232_14125546/ <![CDATA[RNS press release - Motif Bio Presents New Iclaprim Data - ASM Microbe ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190624070013_14120921/ Mon, 24 Jun 2019 02:00:13 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190624070013_14120921/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190620163558_14118926/ Thu, 20 Jun 2019 11:35:58 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190620163558_14118926/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190619170826_14117315/ Wed, 19 Jun 2019 12:08:26 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190619170826_14117315/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190618160547_14115560/ Tue, 18 Jun 2019 11:05:47 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190618160547_14115560/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190614090454_14111319/ Fri, 14 Jun 2019 04:04:54 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190614090454_14111319/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190612175228_14108843/ Wed, 12 Jun 2019 12:52:28 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190612175228_14108843/ <![CDATA[RNS press release - Receipt of FDA Meeting Minutes ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190606070007_14100505/ Thu, 06 Jun 2019 02:00:07 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190606070007_14100505/ <![CDATA[RNS press release - Result of AGM ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190531151504_14094653/ Fri, 31 May 2019 10:15:04 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190531151504_14094653/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190531102845_14094102/ Fri, 31 May 2019 05:28:45 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190531102845_14094102/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190529113652_14090973/ Wed, 29 May 2019 06:36:52 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190529113652_14090973/ <![CDATA[RNS press release - AGM Statement ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190522135003_14083870/ Wed, 22 May 2019 08:50:03 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190522135003_14083870/ <![CDATA[RNS press release - Orphan Disease Opportunity for Iclaprim ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190522070006_14082732/ Wed, 22 May 2019 02:00:06 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190522070006_14082732/ <![CDATA[RNS press release - Iclaprim Data presented at ASM Microbe 2019 ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190521070025_14081007/ Tue, 21 May 2019 02:00:25 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190521070025_14081007/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190520181422_14080784/ Mon, 20 May 2019 13:14:22 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190520181422_14080784/ <![CDATA[RNS press release - Meeting with US FDA held as planned ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190503182503_14063296/ Fri, 03 May 2019 13:25:03 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190503182503_14063296/ <![CDATA[RNS press release - Motif Signs Agreement with Lamellar Biomedical ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190501070014_14058482/ Wed, 01 May 2019 02:00:14 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190501070014_14058482/ <![CDATA[RNS press release - Notice of AGM ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190426070103_14052824/ Fri, 26 Apr 2019 02:01:03 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190426070103_14052824/ <![CDATA[RNS press release - Appointment of Andrew Powell to Board of Directors ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190426070011_14052781/ Fri, 26 Apr 2019 02:00:11 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190426070011_14052781/ <![CDATA[News - Motif Bio higher as it presents data from Phase III iclaprim trial ]]> https://www.proactiveinvestors.com/companies/news/218650/motif-bio-higher-as-it-presents-data-from-phase-iii-iclaprim-trial-218650.html Tue, 16 Apr 2019 07:46:00 -0400 https://www.proactiveinvestors.com/companies/news/218650/motif-bio-higher-as-it-presents-data-from-phase-iii-iclaprim-trial-218650.html <![CDATA[RNS press release - Motif Presents New Iclaprim Data at ECCMID 2019 ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190416070015_14042103/ Tue, 16 Apr 2019 02:00:15 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190416070015_14042103/ <![CDATA[RNS press release - Fiscal Year 2018 Results ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190415070007_14040326/ Mon, 15 Apr 2019 02:00:07 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190415070007_14040326/ <![CDATA[RNS press release - Motif Bio to Present Iclaprim Data at ECCMID 2019 ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190404070013_14028240/ Thu, 04 Apr 2019 02:00:13 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190404070013_14028240/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190402174355_14026227/ Tue, 02 Apr 2019 12:43:55 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190402174355_14026227/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190401152807_14024074/ Mon, 01 Apr 2019 10:28:07 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190401152807_14024074/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190401141735_14023907/ Mon, 01 Apr 2019 09:17:35 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190401141735_14023907/ <![CDATA[RNS press release - Motif Bio Raises £2.7m (US$3.55m) ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190326070017_14015167/ Tue, 26 Mar 2019 03:00:17 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190326070017_14015167/ <![CDATA[RNS press release - Proposed Equity Fundraise ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190325094953_14014125/ Mon, 25 Mar 2019 05:49:53 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190325094953_14014125/ <![CDATA[News - Motif Bio surges as US FDA agrees to a meeting to discuss new drug application for novel antibiotic iclaprim ]]> https://www.proactiveinvestors.com/companies/news/216830/motif-bio-surges-as-us-fda-agrees-to-a-meeting-to-discuss-new-drug-application-for-novel-antibiotic-iclaprim-216830.html Wed, 20 Mar 2019 09:51:00 -0400 https://www.proactiveinvestors.com/companies/news/216830/motif-bio-surges-as-us-fda-agrees-to-a-meeting-to-discuss-new-drug-application-for-novel-antibiotic-iclaprim-216830.html <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190320070010_14008316/ Wed, 20 Mar 2019 03:00:10 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190320070010_14008316/ <![CDATA[RNS press release - Motif Bio Granted Meeting with U.S. FDA ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190320070006_14008292/ Wed, 20 Mar 2019 03:00:06 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190320070006_14008292/ <![CDATA[RNS press release - Appointment of Bruce Williams as Interim Chairman ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190318070007_14005028/ Mon, 18 Mar 2019 03:00:07 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190318070007_14005028/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190315070105_14003292/ Fri, 15 Mar 2019 03:01:05 -0400 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190315070105_14003292/ <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190307120742_13994286/ Thu, 07 Mar 2019 07:07:42 -0500 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190307120742_13994286/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190307120215_13994267/ Thu, 07 Mar 2019 07:02:15 -0500 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190307120215_13994267/ <![CDATA[RNS press release - Conference Call and Webcast ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190219070006_13973516/ Tue, 19 Feb 2019 02:00:06 -0500 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190219070006_13973516/ <![CDATA[RNS press release - Amendment Agreement with Hercules Capital ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190218070008_13971960/ Mon, 18 Feb 2019 02:00:08 -0500 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190218070008_13971960/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190215162840_13971681/ Fri, 15 Feb 2019 11:28:40 -0500 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190215162840_13971681/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190215162646_13971680/ Fri, 15 Feb 2019 11:26:46 -0500 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190215162646_13971680/ <![CDATA[RNS press release - Complete Response Letter from the FDA ]]> https://www.proactiveinvestors.com/companies/rns/10670/LSE20190214070007_13968786/ Thu, 14 Feb 2019 02:00:07 -0500 https://www.proactiveinvestors.com/companies/rns/10670/LSE20190214070007_13968786/